AAP News Vol. 2 No. 6 June 1986, p. 14
© 1986 American Academy of Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

 Previous Article  |  Next Article 

Haemophilus influenzae among topics for CME course

The Haemophilus influenzae b polysaccharide vaccine (HBPV) is a safe vaccine; however, the question now is whether it is effective, says Ellen Wald, M.D., FAAP.

Dr. Wald will discuss Haemophilus influenzae b at the AAP Continuing Medical Education (CME) course "Advances in Pediatrics I," scheduled for Sept. 12-14 in New York. Dr. Wald, associate professor of pediatrics, Children's Hospital of Pittsburgh, is one of four faculty members for the course, which will cover allergy, dermatology, infectious diseases and neurology.